About DermaSensor
DermaSensor is a Healthcare company based in Miami (United States) founded in 2009 by Christopher Dewey. Handheld diagnostic device for skin cancer lesions is developed. It operates in the Healthcare and Technology sectors. DermaSensor has raised $69.75 million across 8 funding rounds from investors including Ceros Capital Markets, David Matlin and Chris Dewey. Its website dermasensor.com draws about 11 thousand monthly visits. DermaSensor offers products and services including DermaSensor Device. Its focus areas include Life Sciences, Oncology, Medical Devices and Imaging. Its legal entity is DERMASENSOR, INC. Its competitors include Zerigo Health and Hememics Biotechnologies; 2 of its 2 listed competitors have raised funding.
Company details
DermaSensor was founded in 2009 and is based in Miami, United States. A handheld diagnostic device for skin cancer is developed by the company within the medical diagnostics sector. Skin lesions are evaluated using elastic scattering spectroscopy, where a light-emitting tip captures cellular irregularities below the surface. Immediate high-risk or low-risk results are provided through proprietary algorithms analyzing reflected photons.
- Total Equity Funding$69.75M (USD)
in 8 rounds
- Latest Funding Round$4M (USD), Series B
Sep 2026
- InvestorsCeros Capital Markets
& 7 more
Products & Services of DermaSensor
DermaSensor offers a comprehensive portfolio of products and services, including DermaSensor Device.
Handheld AI device for non-invasive skin cancer risk assessment.
Apps and channels of DermaSensor
its YouTube channel DermaSensor has 81 subscribers and 23 videos.
Videos from DermaSensor
The most watched videos on DermaSensor's YouTube channel, DermaSensor (81 subscribers). Click a video to play it here.
More on DermaSensor.
Funding Insights of DermaSensor
DermaSensor has successfully raised a total of $69.75M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $4 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $69.75M
- Total Rounds 8
- Last Round Series B — $4M
- First Round $5.81M
(Dec 2018)
- Investors Count 8
All 8 funding rounds of DermaSensor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | $4M | Series B | – | – | – |
| Jun 2026 | $5M | Series B | – | – | – |
| Oct 2025 | $16M | Series B | – | – | |
| Nov 2024 | $8.93M | Series B | – | – | – |
| Jun 2022 | $10M | Series B | – | Ceros Capital Markets | – |
| Dec 2021 | $8.51M | Series A | – | – | – |
| Mar 2020 | $11.5M | Series A | – | David Matlin, Chris Dewey | |
| Dec 2018 | $5.81M | Series A | – | – | – |
8 investors in total: 6 institutional and 2 angel.
Investors in DermaSensor
DermaSensor has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Ceros Capital Markets, David Matlin and Chris Dewey.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are focused on tech startups. | ceroscapitalmarkets.com | Miami, United States | ||
VC and investment banking firm backed by Aegis Capital Corp | sternaegis.com | New York, United States | ||
Early-stage technology companies are funded by Miami Angels. | 2013 | miamiangels.vc | Miami, United States | |
| pier70ventures.com | ||||
Capital resources are stewarded by Kern Venture Group for economic growth. | kernventuregroup.com | Bakersfield, United States | ||
| genhenncapital.com | ||||
DM David Matlin | Angel investor focusing on Indian startups, based in Mumbai. | unknown_a357c2e675424fe29 | ||
CD Chris Dewey | unknown_19d5c303b0be49c1a |
Investor details for DermaSensor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DermaSensor
26 people are tracked at DermaSensor (10 in leadership, 12 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Christopher Dewey | Co-Founder | Leadership |
Cody Simmons | CEO | Leadership |
Justin Frazier | Sr. Director, Clinical Operations | Leadership |
Frank Rios | Area Sales Director | Leadership |
S. Ryan Freiden | COO | Leadership |
Ryan Freiden | VP, Operations & Product | Leadership |
Kevin Scrimshaw | Commercial Director, ANZ | Leadership |
Carolyn Walsh | Chief Commercial Officer (cco) | Leadership |
Jacqueline Barberena | Senior Director Of Marketing | Leadership |
Ruth Stachura | National Sales Director | Leadership |
Paul Salmon | Scientific Advisor | Board & advisors |
David Matlin | Director | Board & advisors |
Cristiane Benvenuto | Scientific Advisor | Board & advisors |
Holly Christman | Scientific Advisor | Board & advisors |
John Geisse | Scientific Advisor | Board & advisors |
Todd Thames | Scientific Advisor | Board & advisors |
David Leffell | Scientific Advisor | Board & advisors |
Maurice Ferre | Co-founder And Chairman | Board & advisors |
Ivan Delevic | Director | Board & advisors |
Irving Bigio | Scientific Advisor | Board & advisors |
6 more people are available in the full profile.
Complete people profiles for DermaSensor
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DermaSensor
3 dated milestones of DermaSensor across 17 years, from founding to its latest funding, stage changes and deals.
- Founded DermaSensor is founded.
- Funding First funding round of $5.8M.
- Funding Latest funding round, Series B, of $4.0M.
Competitors of DermaSensor
DermaSensor has 2 listed competitors in our database, 2 of them funded. They include Zerigo Health and Hememics Biotechnologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zerigohealth.com | 2014 | San Diego, United States | $77.92M | Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema | ||
| hememics.com | 2009 | Gaithersburg, United States | $4.6M | 13 | Biopreservation platform for mammalian cells and biologics is developed. |
Detailed competitors of DermaSensor
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DermaSensor
The website of DermaSensor (dermasensor.com) receives about 10.7K visits a month.
- Monthly visits10.7K
▲ 17.6% vs previous month
Websites whose visitors overlap most with DermaSensor. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| legacymedsearch.com | 100% | #5,132,467 | View details | ||
mirabellespa.com | mirabellespa.com | 98% | – | ||
ptfamilymedicine.com | ptfamilymedicine.com | 98% | #3,916,089 | – | |
dsresearch.com | dsresearch.com | 98% | #4,252,043 | – | |
theseabreezebeacon.com | theseabreezebeacon.com | 97% | #4,869,305 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for DermaSensor
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as DermaSensor (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dermasensor
Complete news archive for DermaSensor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DermaSensor
DermaSensor was founded in 2009 and raised its 1st funding round 9 years after it was founded.
DermaSensor is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
DermaSensor is a funded company, having raised a total of $69.75M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5.81M, raised on Dec 2018.
DermaSensor was founded in 2009 and is based in Miami, United States. A handheld diagnostic device for skin cancer is developed by the company within the medical diagnostics sector. Skin lesions are evaluated using elastic scattering spectroscopy, where a light-emitting tip captures cellular irregularities below the surface. Immediate high-risk or low-risk results are provided through proprietary algorithms analyzing reflected photons.
DermaSensor's top competitors include Hememics Biotechnologies and Zerigo Health.
DermaSensor offers DermaSensor Device.
DermaSensor has 8 investors. Key investors include Ceros Capital Markets, David Matlin, Chris Dewey, SternAegis Ventures, and Miami Angels.
DermaSensor operates through Dermasensor, Inc.